FDA Approves New Workflow Option for Roche’s Cobas HPV Test – GenomeWeb

FDA Approves New Workflow Option for Roche's Cobas HPV Test
NEW YORK (GenomeWeb News) – Roche today said that the US Food and Drug Administration approved a new workflow process for the company's Cobas HPV test. The newly approved workflow option allows for a sample to be processed from the primary 
FDA approves new streamlined workflow option for Roche's cobas HPV TestMarketWatch (press release)

all 3 news articles »

View full post on hpv – Google News

Leave a Reply

Your email address will not be published. Required fields are marked *